Contact Information

C-118 Chandler Medical Center
University of Kentucky
Lexington, KY 40536

phone: 859-257-8403
fax: 859-323-2049

Contact by email

Positions

• Clinical Pharmacist Specialist
  Internal Medicine/Therapeutic
  Drug Monitoring
  
• Program Director, PGY2
  Speciality Residency in
  Adult Internal Medicine
  Pharmacy Services, UK Chandler Medical Center
• Adjunct Assistant Professor
  Pharmacy Practice and Science Department

Education

• B.S. Pharmacy
  Duquesne University, 1998
• Pharm.D.
  Duquesne University, 1999
  

Training

• Pharmacy Practice Residency.
  University Hospital
  Cincinnati, Ohio, 2000

Practice Area

• Adult Internal Medicine
  Clinical Pharmacokinetics
  

Research Interests

• Anticoagulation

Daniel Lewis - Pharm.D., BCPS

Dr. Lewis received his Bachelor's and Doctor of Pharmacy degrees from Duquesne University in 1998 and 1999 and completed a pharmacy practice residency at the University Hospital of Cincinnati in 2000. He serves as the clinical pharmacist for the adult internal medicine services as well as the clinical pharmacokinetics service (CPS) at the University of Kentucky Chandler Medical Center. This position serves to provide comprehensive pharmaceutical care to patients on the Internal Medicine services through integrated drug distribution, clinical rounding services, research and teaching. Other responsibilities include coordination of pharmaceutical care provided to patients receiving anticoagulants and other monitorable drugs. Dr. Lewis serves as co-coordinator and lecturer in the third year advanced pharmacotherapy course. He also provides experiential education to fourth year students through the internal medicine rotation.

Selected Publications/Presentations

• Vincent WR, Martin CA, Winstead PS, Smith KM, Gatz J, Lewis DA. Effects of a Pharmacist-To-Dose Computerized Request on Promptness of Antimicrobial Therapy. J Am Med Inform Assoc. 2009 Jan-Feb;16(1):47-53.
• Farley TM, Lewis DA, Macaulay TE. "Rivaroxaban: A potential replacement for warfarin?" Cardio Rev. 2008;25:9:40-44.
• Reynolds LR, Cook AM, Lewis DA, Colliver C, Legg S, Barnes N, Conigliaro J, Lofgren R. An Institutional Process to Improve Inpatient Glycemic Control. Qual Manag Health Care. 2007 Jul-Sep;16(3):239-49.
• Papadopoulos S, Flynn JD, Lewis DA. The Potential Use of Fondaparinux for the Management of Heparin Induced Thrombocytopenia. Pharmacotherapy 2007;27(6):921-926.
• Vincent W, Smith KM, Winstead PS, Lewis DA. "Review of Alcohol Withdrawal in the Hospitalized Patient: Pharmacologic Management. Orthopedics. 2007 June;30(6):446-9.
• Vincent W, Smith KM, Lewis DA, Winstead PS. "Review of Alcohol Withdrawal in the Hospitalized Patient: Diagnosis and Assessment. Orthopedics. 2007 May;30(5):358-61.
• Toma MB, Winstead PS, Smith KM, Lewis DA, Clifford TM. "Pharmacy Resident Participation in Cardiopulmonary Resuscitation Events" Am J Health-Syst Pharm. 2007;64:747-53.
• Taylor LM, Farzam F, Cook AM, Lewis DA, Baumann MJ, Kuhn RJ. Clinical Utility of Continuous Intravenous Infusion Valproic Acid in Pediatric Patients. Pharmacotherapy 2007;27(4):519-25.
• Antimicrobial therapy and pharmacokinetic considerations KSHP Spring Meeting. Louisville, KY May 2006
• Oh JJ, Akers WS, Lewis D, Ramaiah C, Flynn JD. Recombinant Factor VIIa for Refractory Bleeding Following Cardiac Surgery using a Direct Thrombin Inhibitor to Facilitate Cardiopulmonary Bypass in a patient with Heparin-Induced Thrombocytopenia. Pharmacotherapy. 2006 Apr;26(4):569-577.
• Development and implementation of a strategic plan to meet ASHP 2015 goals in an academic medical center ASHP Midyear meeting. Las Vegas NV, December 2005.
• Weant, KA, Smith KM, Lewis DA. Assessment of Prescriber Compliance with Established Heart Failure Guidelines at a Major Medical Center. Hospital Pharmacy 2005; 40 (8): 680-86.
• Lewis DA, Gurram NR, Abraham WT, Akers WS. Effect of nesiritide versus milrinone on patient outcomes in the treatment of acutely decompensated heart failure. Am J Health Syst Pharm. 2003 Aug 15;60 Suppl 4:S16-20.